International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International AIDS Vaccine Initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9306
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. Its products include mRNA-NFL, BG505 Envelope, eOD Immunogen, AAV-PG9, AD26, MVA, protein and CDV replicating vector, among others. IAVI conducts vaccine trials and related epidemiological research in partnership with academic, biotechnology, pharmaceutical and governmental institutions. The organization partners with government agencies, civil society, clinical, research institutions. It has operations across South Africa, Kenya, India, the US, and the Netherlands. IAVI is headquartered in New York, the US.

International AIDS Vaccine Initiative – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
International AIDS Vaccine Initiative Acquires Clinical Programs and Assets from Aeras TB Vaccine 10
Partnerships 11
IAVI and Serum Institute of India Enter into Development Partnership 11
International AIDS Vaccine Partners with CureVac 12
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 13
Licensing Agreements 14
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 14
International AIDS Vaccine Initiative – Key Competitors 15
International AIDS Vaccine Initiative – Key Employees 16
International AIDS Vaccine Initiative – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
05/31/2018: IAVI, Selexis SA and Collaborators Publish Study Highlighting Improved Approach for Generating Complex Proteins Required for Producing HIV Vaccines 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Key Facts 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Deals By Therapy Area, 2012 to YTD 2018 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International AIDS Vaccine Initiative Acquires Clinical Programs and Assets from Aeras TB Vaccine 10
IAVI and Serum Institute of India Enter into Development Partnership 11
International AIDS Vaccine Partners with CureVac 12
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 13
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 14
International AIDS Vaccine Initiative, Key Competitors 15
International AIDS Vaccine Initiative, Key Employees 16
International AIDS Vaccine Initiative, Other Locations 17

List of Figures
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Barrick Gold Corporation:戦略・SWOT・企業財務分析
    Barrick Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bio Techne Corp (TECH)-製薬・医療分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • China Gas Holdings Ltd (384):企業の財務・戦略的SWOT分析
    China Gas Holdings Ltd (384) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Stellar Biotechnologies Inc (SBOT):企業の財務・戦略的SWOT分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Tessa Therapeutics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that discovers, develops, and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response and identify and exterminate cancer cells. The company provides products …
  • Maruti Suzuki India Ltd (MARUTI):企業の財務・戦略的SWOT分析
    Maruti Suzuki India Ltd (MARUTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Westlake Chemical Corp (WLK):企業の財務・戦略的SWOT分析
    Summary Westlake Chemical Corp (Westlake Chemical) is a chemical company that manufactures and distributes petrochemicals, plastics and building products. The company offers products such as olefins, vinyls, styrene, polyethylene, epolene polymers, and others. It manufactures two primary petrochemic …
  • Asiana Airlines Inc.:企業の戦略・SWOT・財務分析
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • City Holding Co (CHCO):企業の財務・戦略的SWOT分析
    City Holding Co (CHCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AF Gruppen ASA (AFG):企業の財務・戦略的SWOT分析
    AF Gruppen ASA (AFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Enerkem Inc:企業の戦略的SWOT分析
    Enerkem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ruth’s Hospitality Group, Inc.:企業の戦略・SWOT・財務情報
    Ruth's Hospitality Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ruth's Hospitality Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析
    Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Meiji Co Ltd:企業の戦略・SWOT・財務分析
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TS Corp (001790):企業の財務・戦略的SWOT分析
    TS Corp (001790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole …
  • Precision System Science Co Ltd (7707)-医療機器分野:企業M&A・提携分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company’s products include automated nucleic acid isolation system, large sample volume nucleic acid extraction sy …
  • Rum Group for Transportation & Tourism Investment:企業の戦略・SWOT・財務情報
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆